Kala Pharmaceuticals, Inc.
KALANext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for KALA. That does not mean none is planned.
Get an email about KALA's next catalysts
Track Kala Pharmaceuticals (KALA) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 0 past
KALA Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | FQ end Sep/2026 | Call: tbd
Market Overview
Stock performance and key metrics
KPI-121
Dry Eye Syndromes
KPI-121 Ophthalmic Suspension
Kerato Conjunctivitis Sicca
KPI-121 Ophthalmic Suspension dosed
Post Surgical Ocular Inflammation and Pain
KPI-121 Ophthalmic
Dry Eye Syndromes
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
KPI-121 | Phase 3 | Dry Eye Syndromes | - | - |
KPI-121 Ophthalmic Suspension | Phase 3 | Kerato Conjunctivitis Sicca | - | - |
KPI-121 Ophthalmic Suspension dosed | Phase 3 | Post Surgical Ocular Inflammation and Pain | - | - |
KPI-121 Ophthalmic | Phase 3 | Dry Eye Syndromes | - | - |
Dry Eye Syndromes
4 drugs in this indication
Post Surgical Ocular Inflammation and Pain
2 drugs in this indication
Kerato Conjunctivitis Sicca
1 drug in this indication
Ocular Infections, Irritations and Inflammations
1 drug in this indication
Blepharitis
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Kala Pharmaceuticals, Inc.'s drug pipeline?→
CatalystAlert tracks 4 drug candidates in Kala Pharmaceuticals, Inc.'s (KALA) pipeline across Phase 3. Its lead program is KPI-121 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Kala Pharmaceuticals, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Kala Pharmaceuticals, Inc. (KALA) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track KALA biotech catalysts?→
Add KALA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Kala Pharmaceuticals, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.